Lombard Medical announces Aorfix received approval in Japan Lombard Medical announced that its lead product, Aorfix, an endovascular stent graft to treat AAA, has received approval from the Japanese Ministry of Health, Labour and Welfare. Commercial sales will follow reimbursement approval, which the Company anticipates receiving in September. Aorfix will be exclusively distributed by Medico's Hirata.
Lombard Medical announces initiation of the ARCHYTAS global registry Lombard Medical announced the initiation of the ARCHYTAS global registry. The ARCHYTAS registry is a prospective study designed to quantify the clinical outcomes of EVAR with Lombard Medical's Aorfix in a broad cross-section of patients with abdominal aortic aneurysms or AAAs.